Comparing nurse versus doctor monitoring for hiv prevention pill users
Part of Immune system & allergy, Infections clinical trials.
This study will check if having nurses, instead of doctors, monitor your routine care while on PrEP (the HIV prevention pill) is just as good, affordable, and satisfying. If you join, you'd be randomly assigned to either nurse-led or doctor-led visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be assigned male at birth and be at least 18 years old.
- You are currently taking PrEP (the daily pill that helps prevent HIV) and are okay with continuing care at a hospital.
- Your PrEP care is currently managed by a doctor, and you're open to having a nurse take over your follow-up visits.
- You have no kidney problems (your doctor has confirmed your kidney function is normal).
- You are covered by French social security or state medical aid (AME).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an all-in-one HIV prevention package for young men at higher risk of HIV. It combines a new long-acting PrEP (injectable HIV prevention) with mobile health support and sexually transmitted infection prevention. The goal is to see if this comprehensive approach works better than standard care.
This study tests a program that offers HIV testing and connects people to prevention or care right in the Emergency Department. It aims to make it easier for anyone visiting the ER to get the HIV services they need.
This study looks at prescribing PrEP (medication to prevent HIV) in regular doctor's offices. It may help you get easier access to prevention if you're at higher risk.
This study follows adults who are at high risk of getting HIV while they take HIV prevention pills (PrEP). It aims to learn how well PrEP fits real-life use in people at risk and who may need extra care.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.
Hear when a new Pre-exposure Prophylaxis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.